The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

August 27, 2021

Primary Completion Date

October 18, 2024

Study Completion Date

March 31, 2028

Conditions
Deep Venous Insufficiency (Diagnosis)
Interventions
DEVICE

Hancock-Jaffe bioprosthetic venous valve (VenoValve®)

Surgical implantation of the VenoValve device

Trial Locations (29)

10016

NYU Langone, New York

10029

Mount Sinai Hospital, New York

11794

Stony Brook Medicine, New York

12180

St. Peter's Vascular Associates, Troy

12208

Albany Medical Center, Albany

14203

Kaleidahealth, Buffalo

15232

UPMC, Pittsburgh

19096

Lankenau Medical Center, Wynnewood

23507

Sentara, Norfolk

27516

University of North Carolina, Chapel Hill

32547

Coastal Vascular, Fort Walton Beach

33176

Miami Vascular Specialists, Miami

35294

University of Alabama at Birmingham, Birmingham

37232

Vanderbilt University Medical Center, Nashville

40202

University of Louisville, Louisville

43606

Jobst Vascular Institute / Promedica Toledo Hospital, Toledo

44132

University Hospitals Cleveland Medical Center, Cleveland

45220

TriHealth, Cincinnati

46202

Indiana University, Indianapolis

48202

Henry Ford Health System, Detroit

60637

University of Chicago, Chicago

63110

Saint Louis University, St Louis

77030

Houston Methodist Hospital, Houston

84132

University of Utah, Salt Lake City

85719

Pima Heart and Vascular, Tucson

90211

Cedars-Sinai Medical Center, Beverly Hills

06510

Yale school of Medicine, New Haven

02114

Massachusetts General Hospital, Boston

07631

Englewood Health, Englewood

Sponsors
All Listed Sponsors
collaborator

AXIOM Real Time Metrics

UNKNOWN

collaborator

Syntactx

NETWORK

lead

Hancock Jaffe Laboratiores, Inc

NETWORK